At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Double-blind, Double-dummy, Placebo Controlled Multi-centre Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Inhalation Powder and Fluticasone Propionate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents Not Currently Treated With Inhaled Corticosteroids
In Brief
A Phase 3 clinical trial evaluating Fluticasone furoate 50mcg, Fluticasone propionate 100mcg, and 1 other intervention for Asthma. Completed, enrolled 351 participants across 42 sites in 6 countries.
Detailed Summary
A randomised, double-blind, double-dummy, placebo controlled multi-centre study to evaluate the efficacy and safety of fluticasone furoate inhalation powder and fluticasone propionate inhalation powder in the treatment of asthma in adults and adolescents not currently treated with inhaled corticosteroids
Study Details
Timeline
Interventions
Once daily inhalation powder via Novel Dry Powder Inhaler
Twice daily inhalation powder via DISKUS/ACCUHALER
Inhalation powder via Novel Dry Powder Inhaler and DISKUS?ACCUHALER